| BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression E Warner, C Herberts, S Fu, S Yip, A Wong, G Wang, E Ritch, AJ Murtha, ... Clinical Cancer Research 27 (6), 1650-1662, 2021 | 69 | 2021 |
| MDT-15/MED15 permits longevity at low temperature via enhancing lipidostasis and proteostasis D Lee, SWA An, Y Jung, Y Yamaoka, Y Ryu, GYS Goh, A Beigi, JS Yang, ... PLoS biology 17 (8), e3000415, 2019 | 63 | 2019 |
| Survival outcomes associated with first and second-line palliative systemic therapies in patients with metastatic bladder cancer A Beigi, S Vafaei-Nodeh, L Huang, SZ Sun, JJ Ko Current Oncology 28 (5), 3812-3824, 2021 | 5 | 2021 |
| Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations E Warner, S Yip, M Annala, G Wang, A Angeles, A Beigi, E Schonlau, ... CLINICAL CANCER RESEARCH 26 (11), 30-30, 2020 | 2 | 2020 |
| Mediator subunit MDT-15 promotes expression of propionic acid breakdown genes to prevent embryonic lethality in Caenorhabditis elegans GYS Goh, A Beigi, J Yan, KRS Doering, S Taubert G3: Genes, Genomes, Genetics 13 (6), jkad087, 2023 | 1 | 2023 |
| Abstract PR09: frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations E Warner, S Yip, M Annala, G Wang, A Angeles, A Beigi, E Schönlau, ... Clinical Cancer Research 26 (11_Supplement), PR09-PR09, 2020 | 1 | 2020 |
| Survival outcomes associated with different palliative systemic therapies (PSTs) in patients with metastatic bladder cancer (mBC). S Vafaei-Nodeh, A Beigi, L Huang, G Mimmack, SZ Sun, JJ Ko Journal of Clinical Oncology 38 (6_suppl), 450-450, 2020 | 1 | 2020 |
| Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC). S Yip, K Sunderland, A Beigi, A Angeles, D Khalaf, EW Warner, ... Journal of Clinical Oncology 37 (7_suppl), 159-159, 2019 | 1 | 2019 |
| C. elegans Mediator 15 permits low temperature-induced longevity via regulation of lipid and protein homeostasis D Lee, SWA An, Y Jung, Y Yamaoka, Y Ryu, GYS Goh, A Beigi, D Ma, ... bioRxiv, 366153, 2018 | 1 | 2018 |
| Clinical Predictors of Germline DNA Damage Repair Gene Mutations in Patients with Advanced Prostate Cancer S Yip, K Sunderland, E Ledet, A Beigi, A Angeles, D Khalaf, R Sabol, ... | | 2023 |
| Current trends and clinical outcomes in patients with locally advanced muscle-invasive bladder cancer undergoing radical treatment in British Columbia, Canada A Beigi, S Vafaei-Nodeh, L Huang, G Mimmack, SZ Sun, JJ Ko Current Oncology 27 (4), e409-e409, 2020 | | 2020 |
| Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations. S Yip, A Angeles, A Beigi, EW Warner, D Khalaf, K Sunderland, ... Journal of Clinical Oncology 36 (15_suppl), 5069-5069, 2018 | | 2018 |
